全球止血閥市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計止血閥市場將從 2025 年的 2.0287 億美元成長到 2034 年的 3.5516 億美元，2026 年至 2034 年的複合年成長率為 6.42%。

隨著介入手術和影像導引治療的日益增多（這些手術和治療通常需要經導管入路），止血瓣膜市場正在不斷擴大。止血瓣膜能夠在防止出血的同時，方便器械更換，是血管外科、心臟病學和介入放射學實踐中不可或缺的工具。心血管疾病盛行率的上升、人口老化以及微創介入手術數量的增加，都推動了止血瓣膜市場的成長。臨床醫師重視那些能夠改善手術流程、降低血液暴露風險並與多種尺寸導管鞘套相容的止血瓣膜。

產品創新（小型化、改進的密封材料以及與高流量導管的兼容性）是推動市場發展的關鍵因素。醫院正在尋求能夠縮短手術時間、降低耗材成本並符合滅菌標準的止血閥。門診手術中心和日間手術設施的擴張正在推動一次性無菌止血裝置的應用。此外，檢驗的、能夠簡化導管更換並減少併發症的工具的推出，正在促進培訓和操作流程的標準化，並提高使用率。

展望未來，隨著介入性心臟病學和血管內腫瘤學手術的增加，市場需求預計將持續成長。新型瓣膜材料和複合裝置（瓣膜+植入器）將提升產品的易用性。新興市場蘊藏成長機遇，這些市場微創手術正在普及，門診介入服務也不斷增加。能夠提供多種尺寸規格和檢驗數據的製造商將獲得競爭優勢。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球止血閥市場：按類型分類

• 市場分析、洞察與預測
• 止血閥Y型接頭
• 雙Y型接頭止血閥
• 單手止血閥
• 其他

第5章 全球止血閥市場：依應用分類

• 市場分析、洞察與預測
• 血管造影術
• 血管成形術

第6章：全球止血閥市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第7章 全球止血閥市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Merit Medical Systems
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Abbott
  • Argon Medical Devices
  • Freudenberg Medical
  • SCW Medicath Ltd
  • Lepu Medical Technology（Beijing）Co. Ltd
  • Nipro
  • DeRoyal Industries Inc
  • Antmed Corporation
  • Beijing Demax Medical Technology Co

The Hemostasis Valves Market size is expected to reach USD 355.16 Million in 2034 from USD 202.87 Million (2025) growing at a CAGR of 6.42% during 2026-2034.

The hemostasis valves market is expanding alongside rising interventional procedures and image-guided therapies where catheter-based access is routine. Hemostasis valves, which prevent blood loss while allowing instrument exchange, are essential for vascular, cardiology, and interventional radiology suites. Growth is propelled by increasing cardiovascular disease prevalence, aging populations, and higher procedural volumes for minimally invasive interventions. Clinicians value valves that improve workflow, reduce blood exposure risk, and integrate with a range of sheath sizes.

Product innovation-miniaturized designs, improved seal materials, and compatibility with high-flow catheters-is an important market driver. Hospitals seek valves that reduce procedural time and consumable costs while complying with sterility standards. Expansion of outpatient interventional centers and ambulatory surgical settings supports adoption of single-use, sterile hemostasis devices. Training and procedural standardization also increase utilization, as teams adopt validated tools that simplify catheter exchanges and reduce complications.

Looking forward, demand should continue as interventional cardiology and endovascular oncology procedures rise. New valve materials and combination devices (valve plus introducer) will improve ease of use. Growth opportunities include emerging markets where minimally invasive procedural capacity is scaling and outpatient interventional services are expanding. Manufacturers that offer breadth of sizes and validated clinical data will gain competitive advantage.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Hemostasis Valve Y- Connectors
• Double Y- Connector Hemostasis Valves
• One- Handed Hemostasis Valves
• Others

By Application

• Angiography
• Angioplasty

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Boston Scientific Corporation, Teleflex Incorporated, Merit Medical Systems, B Braun Melsungen AG, Terumo Corporation, Abbott, Argon Medical Devices, Freudenberg Medical, SCW Medicath Ltd, Lepu Medical TechnologyBeijingCo Ltd, Nipro, DeRoyal Industries Inc, Antmed Corporation, Beijing Demax Medical Technology Co
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS VALVES MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Hemostasis Valve Y- Connectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Double Y- Connector Hemostasis Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. One- Handed Hemostasis Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS VALVES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Angiography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Angioplasty Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS VALVES MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS VALVES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMOSTASIS VALVES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Boston Scientific Corporation
  • 9.2.2 Teleflex Incorporated
  • 9.2.3 Merit Medical Systems
  • 9.2.4 B. Braun Melsungen AG
  • 9.2.5 Terumo Corporation
  • 9.2.6 Abbott
  • 9.2.7 Argon Medical Devices
  • 9.2.8 Freudenberg Medical
  • 9.2.9 SCW Medicath Ltd
  • 9.2.10 Lepu Medical Technology(Beijing)Co. Ltd
  • 9.2.11 Nipro
  • 9.2.12 DeRoyal Industries Inc
  • 9.2.13 Antmed Corporation
  • 9.2.14 Beijing Demax Medical Technology Co